Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pitolisant oxalate is a potent and selective inverse agonist of nonimidazole at the recombinant human histamine H3 receptor with Ki of 0.16 nM. 在相同实验条件下,摩尔浓度相同的化合物盐形式与游离态具有相同的生物活性,但盐形式 Pitolisant hydrochloride 的水溶性和稳定性通常比游离态更好。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | ||
50 mg | ¥ 13,800 | 6-8周 | ||
100 mg | ¥ 17,500 | 6-8周 |
Pitolisant oxalate 的其他形式现货产品:
产品描述 | Pitolisant oxalate is a potent and selective inverse agonist of nonimidazole at the recombinant human histamine H3 receptor with Ki of 0.16 nM. |
靶点活性 | H3 receptor:0.16 nM (Ki), H3 receptor:1.5 nM (EC50) |
体外活性 | Pitolisant behaves as a competitive antagonist with a Ki value of 0.16 nM and as an inverse agonist with an EC50 value of 1.5 nM and an intrinsic activity ~50% higher than that of ciproxifan. |
体内活性 | The administration of Pitolisantat a single dose of 10 mg/kg 30 min before a single dose of Olanzapine (2 mg/kg b.w.) also significantly affects immobility time in the FST. Subsequent administration of the aforementioned drug sequence in mice statistically significantly increases the duration of immobility in comparison to the time determined in the control group in the FST. It decreased locomotor activity as well[3] |
别名 | Tiprolisant oxalate |
分子量 | 385.88 |
分子式 | C19H28ClNO5 |
CAS No. | 362665-57-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (129.57 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5915 mL | 12.9574 mL | 25.9148 mL | 64.787 mL |
5 mM | 0.5183 mL | 2.5915 mL | 5.183 mL | 12.9574 mL | |
10 mM | 0.2591 mL | 1.2957 mL | 2.5915 mL | 6.4787 mL | |
20 mM | 0.1296 mL | 0.6479 mL | 1.2957 mL | 3.2393 mL | |
50 mM | 0.0518 mL | 0.2591 mL | 0.5183 mL | 1.2957 mL | |
100 mM | 0.0259 mL | 0.1296 mL | 0.2591 mL | 0.6479 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Pitolisant oxalate 362665-57-4 Others Pitolisant Oxalate Tiprolisant Oxalate Tiprolisant oxalate Inhibitor inhibitor inhibit